1Rivero A,Mora C,Muros M. Pathogenic perspectives for the role of inflammation in diabetic nephropathy[J].Clinical Science(London),2009,(06):479-492.
2Ruster C,Wolf G. The role of chemokines and chemokine receptors in diabetic nephropathy[J].Frontiers in Bioscience,2008,(08):944-955.
3Usui HK,Shikata K,Sasaki M. Macrophage scavenge receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation[J].Diabetes,2007,(02):363-372.doi:10.2337/db06-0359.
4Tesch GH. MCP-1/CCL2:a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy[J].American Journal of Physiology-Renal Physiology,2008,(04):697-701.
5Rovin BH,Lu L,Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression[J].Biochemical and Biophysical Research Communications,1999,(02):344-348.
6Yang B,Houlberg K,Millward A. Polymorphisms of chemokine and chemokine receptor genes in type 1 diabetes mellitus and its complications[J].Cytokine,2004,(03):114-121.
7Kim HL,Lee DS,Yang SH. The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE[J].American Journal of Kidney Diseases,2002,(06):1146-1152.
8Karrer S,Bosserhoff AK,Weiderer P. The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic selerosis[J].Journal of Investigative Dermatology,2005,(01):92-98.
9Lee SH,Ryu JK,Jeong JB. Polymorphisms of the MCP-1 and HSP70-2 genes in korean patients with alcoholic chronic pancreatitis[J].Digestive Diseases and Sciences,2008,(06):1721-1727.doi:10.1007/s10620-007-0049-1.
10Jemaa R,Rojbani H,Kallel A. Association between the-2518G /A polymorphism in the monocyte chemoattractant protein-1(MCP-1) gene and myocardial infarction in Tunisan patients[J].Clin Chmi Acta,2008,(1/2):122-125.
